Merck & Co., Inc. (NYSE:MRK) Gets FDA Nod For ZERBAXA

Donna Fago - June 4, 2019

Merck & Co., Inc. (NYSE:MRK) reported that the U.S. Food and Drug Administration has approved expanded use of its antibiotic to cure hospital-acquired pneumonia in people 18 years and older....

How Egalet Corp (NASDAQ:EGLT) Fared In Q3 2017?

admin - November 21, 2017

Egalet Corp (NASDAQ:EGLT) issued financial report for the third quarter closed September 30, 2017. As of September 30, 2017, the company recorded cash/cash equivalents and marketable securities of $102.1 million....

Sign Up To Get Our Latest Stocks Alerts